In an MHCIIΔILC3 murine CRC model, it was demonstrated that MHC II+ ILC3s supported the colonization of gut microbiota that boosted the anti-tumor properties of Th1 and T-bet+ CD8+ T cells [152]. The gene discussed is CD8A; the disease is neoplasm.